{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:27:00Z","timestamp":1761532020873,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.brachy.2020.02.007","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T07:55:27Z","timestamp":1585814127000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the urethral \u03b1\/\u03b2 ratio and tissue repair half-time for iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Toshio","family":"Gocho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-7754","authenticated-orcid":false,"given":"Masanori","family":"Someya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Hareyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8665-7948","authenticated-orcid":false,"given":"Masaru","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2020.02.007_bib1","series-title":"Perez and Brady\u02bcs principles and practice of radiation oncology","first-page":"1560","article-title":"Low-risk prostate cancer","author":"Perez","year":"2018"},{"key":"10.1016\/j.brachy.2020.02.007_bib2","series-title":"Perez and Brady\u02bcs principles and practice of radiation oncology","first-page":"1602","article-title":"Management of intermediate- and high- risk prostate cancer: what do we know?","author":"Roach","year":"2018"},{"key":"10.1016\/j.brachy.2020.02.007_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.brachy.2015.12.011","article-title":"Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy","volume":"15","author":"Eriguchi","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.02.007_bib4","first-page":"975","article-title":"Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer","volume":"164","author":"Crook","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.brachy.2020.02.007_bib5","first-page":"825","article-title":"Biologically effective dose (BED) correlation with biochemical control after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer","volume":"55","author":"Edward","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.02.007_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.02.007_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jjco\/hyx181","article-title":"Prediction of acute gastrointestinal and genitourinary radiation toxicity in prostate cancer patients using lymphocyte microRNA","volume":"48","author":"Someya","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.brachy.2020.02.007_bib9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.brachy.2019.03.007","article-title":"Genitourinary toxicity after permanent iodine-125 seed implantation: the nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)","volume":"18","author":"Tanaka","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.02.007_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijrobp.2014.06.037","article-title":"Late urinary side effects 10 years after low-dose-rate prostate brachytherapy: population-based results from a multi physician practice treating with a standardized protocol and uniform dosimetric goals","volume":"90","author":"Mira","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.02.007_bib11","series-title":"2nd International Symposium on Information Theory","first-page":"267","article-title":"Information theory and an extension of the maximum likelihood principle","author":"Akaike","year":"1973"},{"key":"10.1016\/j.brachy.2020.02.007_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.brachy.2020.02.007_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10147-014-0704-4","article-title":"Nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)","volume":"20","author":"Saito","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.brachy.2020.02.007_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.brachy.2015.09.011","article-title":"Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?","volume":"15","author":"Merrick","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.02.007_bib15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.brachy.2017.05.009","article-title":"Focal brachytherapy for localized prostate cancer: urinary toxicity depends on tumor location","volume":"16","author":"Srougi","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.02.007_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.02.007_bib17","series-title":"The GEC-ESTRO Handbook of Brachytherapy","first-page":"95","article-title":"Radiobiology of brachytherapy and the dose-rate effect","author":"Mazeron","year":"2002"},{"key":"10.1016\/j.brachy.2020.02.007_bib18","series-title":"Basic clinical radiobiology","first-page":"158","article-title":"The dose-rate effect","author":"Van der Kogel","year":"2009"},{"key":"10.1016\/j.brachy.2020.02.007_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1259\/0007-1285-58-690-515","article-title":"The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy","volume":"58","author":"Dale","year":"1985","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2020.02.007_bib20","series-title":"Basic clinical radiobiology","first-page":"102","article-title":"Fractionation: the linear quadratic approach","author":"Joiner","year":"2009"},{"key":"10.1016\/j.brachy.2020.02.007_bib21","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international datasets: alpha\/beta\u00a0= 1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.02.007_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is alpha\/beta for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120300179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120300179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:15:09Z","timestamp":1761531309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472120300179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1538472120300179"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2020.02.007","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the urethral \u03b1\/\u03b2 ratio and tissue repair half-time for iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2020.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}